Oncologist Chelsea Tripp and clinical pathologist Anna Meredith host this session that discusses the background, presentation, grading, behavior, prognosis, and treatment options for mast cell tumors (MCTs).
This side-by-side conversation between Dr. Tripp and Dr. Meredith will guide you on how to approach clinical cases involving MCTs, the difference between cytologic and histopathologic grading, and how to work through cases with discrepant diagnostic information.
They will also cover how to decipher histopathology and cytology reports, examine treatment options, then review several clinical cases so you can see the process from beginning to end.
Learning Objectives
- Mast Cell Tumor (MCT) overview
- Definition, origin, predisposition, and clinical relevance
- Spectrum, properties, and types
- Diagnostic grading and characteristics
- Proper staging
- Prognostic factors
- Making sense of pathology reports
- Treatment options for low, intermediate, and high-grade MCTs
- How to speak to pet owners about the initial diagnosis and general treatment approach of MCT-specific oncology cases
Please note that the original speaker will not be available to answer questions submitted for on-demand webinars. Our medical team will answer any questions to the best of their availability, but this may not be possible depending on the question submitted.